pharmaceutical daily

ALBUQUERQUE, N.M.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/NCI?src=hash" target="_blank"gt;#NCIlt;/agt;–AgilVax, Inc., a biotechnology company developing targeted antibody-based therapies for the treatment of various cancers, including…

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement…

WATERTOWN, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24TTPH&src=ctag" target="_blank"gt;$TTPHlt;/agt; lt;a href="https://twitter.com/hashtag/antibioticresistance?src=hash" target="_blank"gt;#antibioticresistancelt;/agt;–Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel…

WAYNE, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced a $37…

Preparatory work for an end-of-Phase II FDA meeting to initiate a Phase III study in liver cancer is ongoing Top-line…

CAMBRIDGE, England–(BUSINESS WIRE)–Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T-cell enhancing therapeutics, today announced that it has…

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Imara, Inc., a clinical-stage biopharmaceutical company focused on sickle cell disease and other hemoglobinopathies, today announced that the…

LEHI, Utah–(BUSINESS WIRE)–Frelii Inc. (OTCQB: FRLI) (“Frelii” or “the Company”) today announced it has issued a press release with the…

LONDON–(BUSINESS WIRE)–Citi, acting through Citibank N.A., has been appointed by Bicycle Therapeutics plc, a biotechnology company pioneering a new class…